CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Cascadian Therapeutics, Inc.  (CASC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 

Cascadian Therapeutics's Quick Ratio

CASC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

CASC Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Jun 30 2016)
II. Quarter


Y / Y Current Liabilities Change - - - - -
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 24.59 7.46 13.79 - -
Overall Ranking # 113 # 363 # # 230 #
Seq. Current Liabilities Change -39.21 % 43.53 % - - -
Seq. Cash & cash equivalent Change 100.44 % -22.35 % - - -



Quick Ratio first quarter 2017 Comment
Cascadian Therapeutics's Cash & cash equivalent grew by 100.44 % in I. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Cascadian Therapeutics's Quick Ratio to 24.59, Quick Ratio remained below Cascadian Therapeutics, Inc. average.

Within Medical Laboratories industry only one company achieved higher Quick Ratio in first quarter 2017. While Quick Ratio total ranking has improved so far to 113, from total ranking in previous quarter at 363.

Explain Quick Ratio?
What are CASC Segments?
See Quick Ratio CASC on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 2
Sector # 19
S&P 500 # 113


Quick Ratio Statistics
High Average Low
24.59 15.28 7.46
(Mar 31 2017)   (Dec 31 2016)


You need to upgrade your Flash Player


Financial Statements
Cascadian Therapeutics's Current Liabilities $ 5 Millions Visit CASC's Balance sheet
Cascadian Therapeutics's Cash & cash equivalent $ 126 Millions Visit CASC's Balance sheet
Source of CASC's Sales Visit CASC's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Medical Laboratories Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Nanoviricides, Inc.  48.73 $ 16.159  Millions$ 0.332  Millions
Cascadian Therapeutics, Inc.  24.59 $ 125.889  Millions$ 5.119  Millions
Exact Sciences Corp  9.17 $ 274.670  Millions$ 29.937  Millions
Evolutionary Genomics, Inc.  7.66 $ 1.801  Millions$ 0.235  Millions
Miragen Therapeutics, Inc.  7.46 $ 54.273  Millions$ 7.279  Millions
Pieris Pharmaceuticals, Inc.  6.51 $ 55.242  Millions$ 8.486  Millions
Veracyte, Inc.  5.49 $ 51.626  Millions$ 9.411  Millions
Prolung Inc  4.96 $ 1.549  Millions$ 0.312  Millions
Cleveland Biolabs Inc  4.96 $ 13.074  Millions$ 2.636  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com